Artificial intelligence is transforming food innovation by accelerating ingredient discovery, optimizing formulations, and enabling personalized nutrition strategies to improve public health outcomes.
Barclays 28th Annual Global Healthcare Conference March 10, 2026 3:00 PM EDTCompany ParticipantsEmily Leproust ...
A Rothbardian view of vaccines and society is that no government should have the power to coerce someone into having a vaccine. Their safety is irrelevant for ...
Agentic AI could reshape drug development. In this interview, Dr. Claudio D’Ambrosio discusses how agentic AI can identify novel drug compounds, improve trial design, and reduce operational ...
Industry’s Most Comprehensive Generative AI Solution Introduces New Agentic Capabilities, Demonstrates Impact Across Hundreds of Global Matters ...
In a year defined by transformation, The University of Texas at San Antonio (UT San Antonio) has emerged as a unified academic powerhouse, bringing together world-class research, clinical care and ...
Therapeutic developers are increasingly rebuilding their workflows around AI to bring drugs to patients faster.
Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.
Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...
Women’s Day is a moment to recognise women who have shaped different fields, including technology and artificial intelligence ...
TTEC’s award-winning Learning Wizard Suite uses AI plus neuroscience to to cut curriculum costs by 88% and finish curriculums in hours, not weeks.
Pacific Northwest National Laboratory (PNNL) has joined the U.S. Department of Energy's Genesis Mission to harness AI for advancements in science, energy and national security, PNNL announced.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results